Compassus Taps Biopharma Growth Executive as Chief Growth Officer
Event summary
- Chris Core joins Compassus as Chief Growth Officer on March 17, 2026.
- Core previously scaled Lumexa Imaging from 20 to 180 imaging centers nationwide.
- Bringing 25+ years of healthcare leadership across biopharma and services sectors.
- Compassus operates 300 programs in 33 states with 10,000 employees.
The big picture
The hire signals Compassus' aggressive growth ambitions in the rapidly consolidating home-based care sector. Core's experience bridging biopharma commercialization with healthcare services could prove valuable as payors increasingly demand integrated care models. The move comes amid growing competition from both traditional hospice providers and tech-enabled home health startups.
What we're watching
- Scaling Strategy
- Whether Core can replicate his rapid scaling success from Lumexa Imaging in Compassus' fragmented home-based care market.
- Market Expansion
- The pace at which Compassus expands its 300-program footprint across additional states beyond the current 33.
- Integration Challenge
- How Core's biopharma background will translate to managing Compassus' diverse service lines including hospice, palliative care, and home infusion.
Our editorial coverage: